AJOVista’s bluebird bio BLUE Stock Holding History

AJOVista’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-960	Closed	-$24.6K	–	77
2024 Q1	$24.6K	Buy	+960	New	+$24.6K	0.07%	80

Other funds holding BLUE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AJOVista's BLUE Position: Q2 2024 in Review

AJOVista sold out of bluebird bio (BLUE) in Q2 2024, closing a stake of 960 shares — an estimated $24.6K sold.

AJOVista first reported a position in BLUE in Q1 2024 and held it in 1 quarter. The position peaked at $24.6K in Q1 2024. 150 funds tracked by Wall St. Rank hold BLUE as of Q2 2024.

AJOVista reported no remaining bluebird bio position as of Q2 2024 after selling out during the quarter.
AJOVista sold 960 bluebird bio shares in Q2 2024, an estimated $24.6K.
AJOVista first reported a position in bluebird bio in Q1 2024 and held it in 1 quarter.
AJOVista's bluebird bio position peaked at $24.6K in Q1 2024.
150 funds tracked by Wall St. Rank held bluebird bio as of Q2 2024.

Based on AJOVista's 13F filing for Q2 2024, filed 13 Aug 2024.